Careteq Ltd (ASX: CTQ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Careteq Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.06 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 235.55 million
Earnings per share -0.019
Dividend per share N/A
Year To Date Return -55.17%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Careteq Ltd (ASX: CTQ)
    Latest News

    A frustrated male investor frowns with his hands and arms open asking why the share price has dropped today.
    Share Fallers

    Why Accent, Careteq, Pro Medicus, and Xero shares are dropping

    These ASX shares are starting the week in the red...

    Read more »

    an elderly couple site together on a sofa in their home with the old man leaning forward on his walking stick and the elderly woman beside him offering comfort by resting her hand on his shoulder.
    IPOs

    This ASX share just dived 25% following its IPO. What happened?

    Not all floats rise to the top...

    Read more »

    CTQ ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Careteq Ltd

    Careteq Ltd is focused on delivering technology solutions for Health and Aged Care. Its solution eazense employs radar technology that provides continuous non-invasive monitoring, allowing care resources to be managed efficiently. The company's other solutions include Sofihub and Wardmm. Its operating segments are Careteq Ltd, Careteq International Inc (US) and Embedded Health Solutions.

    CTQ Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    16 Apr 2024 $0.01 $0.00 0.00% 70,000 $0.01 $0.01 $0.01
    12 Apr 2024 $0.01 $0.00 0.00% 1,882,614 $0.01 $0.01 $0.01
    11 Apr 2024 $0.01 $0.00 0.00% 230,000 $0.01 $0.01 $0.01
    09 Apr 2024 $0.01 $0.00 0.00% 573,282 $0.01 $0.01 $0.01
    08 Apr 2024 $0.01 $0.00 0.00% 6,600 $0.01 $0.01 $0.01
    05 Apr 2024 $0.01 $0.00 0.00% 536,783 $0.02 $0.02 $0.01
    03 Apr 2024 $0.02 $0.00 0.00% 500,000 $0.02 $0.02 $0.02
    28 Mar 2024 $0.02 $0.00 0.00% 2,244,301 $0.02 $0.02 $0.02
    27 Mar 2024 $0.02 $0.00 0.00% 775,217 $0.01 $0.02 $0.01
    26 Mar 2024 $0.02 $0.00 0.00% 1,615,054 $0.02 $0.02 $0.02
    25 Mar 2024 $0.02 $0.00 0.00% 820,253 $0.02 $0.02 $0.02
    22 Mar 2024 $0.02 $0.00 0.00% 2,216,720 $0.02 $0.02 $0.02
    21 Mar 2024 $0.02 $0.00 0.00% 2,025,888 $0.02 $0.02 $0.01
    20 Mar 2024 $0.02 $0.00 0.00% 2,893,751 $0.02 $0.02 $0.02
    19 Mar 2024 $0.02 $0.00 0.00% 1,915,320 $0.02 $0.02 $0.02

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Dec 2023 Brett Cheong Expiry 584,482 $16,365
    Options expired.
    15 Dec 2023 Alexander (Alex) Boyd Expiry 1,578,101 $44,186
    Options expired.
    15 Dec 2023 Mark Simari Expiry 1,168,965 $32,731
    Options expired.
    17 Oct 2023 Mark Simari Buy 200,000 $4,900
    On-market trade.
    11 Sep 2023 Mark Simari Buy 525,000 $11,497
    On-market trade.
    18 Aug 2023 Stephen Munday Issued 80,000 $2,000
    Rights issue.
    18 Aug 2023 Alexander (Alex) Boyd Issued 120,000 $3,000
    Rights issue.
    18 Aug 2023 Brett Cheong Issued 333,333 $8,333
    Rights issue.
    18 Aug 2023 Mark Simari Issued 40,000 $1,000
    Rights issue.
    18 Aug 2023 Mark Simari Issued 1,200,000 $30,000
    Rights issue.
    30 May 2023 Mark Simari Buy 150,000 $7,590
    On-market trade.
    26 May 2023 Mark Simari Buy 374,038 $19,188
    On-market trade.
    17 May 2023 Mark Simari Buy 165,577 $8,543
    On-market trade.
    09 May 2023 Mark Simari Buy 109,600 $5,589
    On-market trade.
    03 May 2023 Mark Simari Buy 45,300 $2,323
    On-market trade. As per announcement on 03-05-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Stephen John Munday Non-Executive Director Nov 2021
    Mr Munday has more than 25 years of experience on or working directly with Boards in a range of organisations. Stephen has over 40 years business experience in Australia and North America including chief financial officer & company secretary positions in several listed companies over that time. Stephen's experience includes a range of responsibilities in management functions including marketing, business development, supply management, commercial management, financial management and change management. Stephen has been working in the health care sector since 2015. He is currently involved in businesses which supply products, services and technologies to the APAC health care and Australian aged care markets.
    Mr Mark Anthony Simari Non-Executive ChairmanNon-Executive Director Apr 2022
    Mr Simari is experienced in the health industry and has over 14 years of experience in a diverse range of organisations.
    Mr Brett Anthony Cheong Non-Executive Director Dec 2019
    Mr Cheong has over 40 years of experience within the healthcare industry at all levels of management. Brett's experience spans sales and marketing, product design and development and manufacturing and product sourcing.
    Mr Alexander (Alex) Ian Fitzgerald Boyd Chief Operating OfficerExecutive Director Dec 2019
    Mr Boyd has experience in international operations, procurement, and resource management across multiple sectors at a C-Suite level. Alex's background includes roles as interim Managing Director leading to a trade sale at Fix My Truck and Operations Director leading to the restructure of a group out of voluntary administration at Fusion Retail Brands. In addition, Alex supervised the integration of three acquired companies at Idox Plc, UK.
    Ms Elizabeth Ann Whitelock Chief Executive Officer Mar 2024
    -
    Mr David Lilja Company Secretary
    -
    Elizabeth Ann Whitelock Chief Executive Officer
    -
    David Lilja Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    DMX Asset Management Limited 25,907,512 11.49%
    Dempsey Capital Pty Ltd 15,367,084 6.81%
    HSBC Custody Nominees 10,307,198 4.57%
    Mr Mark Simari 9,863,812 4.37%
    JTO Flinders Pty Ltd 8,635,837 3.83%
    BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd (Drp A/C) 8,145,564 3.61%
    JMT Investment Group 8,135,069 3.61%
    National Nominees Limited 7,109,578 3.15%
    Growth Endeavours / Ascent Super Fund 6,334,294 2.81%
    Vanward Investments Limited 6,280,000 2.78%
    Scintilla Strategic Investments Limited 6,000,000 2.66%
    Deakin University 4,995,571 2.21%
    HSBC Custody Nominees (Australia) Limited A/C 2 4,896,834 2.17%
    Silver Cloud 4,687,158 2.08%
    Morsec Nominees Pty Ltd (Accumulation Account) 4,685,000 2.08%
    Covenant Holdings (Wa) Pty Ltd 4,404,277 1.95%
    Ian Heraud Holdings Pty Ltd (The Heraud Family A/C) 4,074,008 1.81%
    Snowball Asset Management Pty Ltd (Snowball Unit A/C) 3,454,335 1.53%
    ABCK Investments Trust 3,172,774 1.41%
    Mountney Limited 3,086,433 1.37%

    Profile

    since

    Note